Related Experiment Videos
Recurrent sickle cell nephropathy in a transplanted kidney
D J Miner1, D K Jorkasky, L J Perloff
1Department of Medicine, University of Pennsylvania, Philadelphia 19104.
Summary
Sickle cell anemia patients may experience kidney transplant success, but recurrence of sickle cell nephropathy can cause long-term kidney function decline. This case highlights the risk of disease recurrence after transplantation.
Area of Science:
- Nephrology
- Hematology
- Transplantation Immunology
Background:
- Sickle cell anemia (SCA) frequently leads to end-stage renal disease (ESRD).
- Renal transplantation is a treatment option for SCA patients with ESRD, offering potential for improved outcomes.
- Recurrence of the primary disease in the transplanted organ is a known complication in some transplant scenarios.
Observation:
- A patient with SCA and a functioning kidney transplant experienced a significant decline in renal function 3.5 years post-transplant.
- The patient's clinical presentation and diagnostic evaluations were consistent with a return of sickle cell-related kidney damage.
Findings:
- Evidence suggests the recurrence of sickle cell nephropathy in the transplanted kidney was the cause of the observed renal dysfunction.
- This indicates that the underlying pathology of SCA can affect allograft function over time.
Implications:
- The findings underscore the potential for sickle cell nephropathy to recur in transplanted kidneys, necessitating long-term monitoring.
- This highlights the importance of understanding the long-term risks and developing strategies to mitigate disease recurrence in SCA patients post-transplant.
- Further research is needed to elucidate the mechanisms of recurrence and optimize management protocols.